题名 | An open-label, phase 2 trial of bicalutamide dose escalation from 50 mg to 150 mg in men with CAB and castration resistance. A Canadian Urology Research Consortium Study |
链接 | http://www.ncbi.nlm.nih.gov/pubmed/25179591 |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |